Exciting Partnership for Skincare Innovations
Pluri Inc. has taken a significant step forward in the health and aesthetics sector with the creation of its subsidiary, Cellav. This new entity leverages Pluri's unique 3D cell expansion technology to innovate in exosome-based solutions tailored for medical aesthetics. This exciting development showcases Pluri's commitment to advancing beauty and wellness through cutting-edge science.
Collaboration with Miss Universe Skincare
The partnership with Miss Universe Skincare represents a major move into the beauty market, a sector projected to grow significantly in the coming years. This collaboration aims to establish a global distribution channel, enabling the delivery of advanced skincare products to a broad audience. As the market evolves, this strategic alliance emphasizes the need for science-backed skincare solutions.
What's New from Cellav?
Cellav is set to utilize its proprietary cell-based active ingredients, developed from Pluri's platform, to craft a new range of skincare products under the Miss Universe Skincare brand. The initial product is anticipated to be unveiled in the first half of 2026 and will be distributed through Miss Universe Skincare's established channels, enhancing the accessibility of regenerative skincare to consumers worldwide.
Exosome Technology in Skincare
The unique approach of this collaboration focuses on the benefits of exosome technology, which is at the forefront of skincare innovation. Exosomes derived from regenerative biotechnology are proven to improve skin rejuvenation, enhancing elasticity and radiance. This integration of biotechnological advancements in beauty could redefine skincare products and how they interact with the skin.
Statements from Leadership
Olivia Quido, President of Miss Universe Skincare, expressed her excitement for the collaboration, stating, "We believe that true beauty begins at the cellular level. Through our partnership, we are poised to introduce the remarkable benefits of exosome technology to our clientele." This sentiment is echoed by Katty Dowery, Cellav's CEO, who emphasizes the potential of regenerative science to impact everyday beauty.
Market Impact and Business Model
Cellav's strategy is intentionally designed to adapt to market demands, focusing on premium, cell-derived ingredients such as exosomes and extracts. It aims to serve various sectors including beauty brands and medical clinics, enhancing its offerings through licensing and joint ventures. This innovative business model represents a shift towards sustainable beauty solutions that align with modern consumer preferences.
According to Yaky Yanay, CEO of Pluri, this collaboration is not merely a brand partnership, but a strategic move to leverage Pluri's technologies where they will have the most significant impact. By entering this high-demand market with differentiated offerings, Pluri is positioned to drive growth while meeting rising consumer expectations for quality and integrity in skincare.
About Cellav and Pluri
Cellav is Pluri's dedicated venture that transforms advanced cell science into practical, aesthetic solutions. By integrating scientific rigor with business acumen, Cellav delivers innovative products that cater to the growing demand for regenerative beauty solutions. On the other hand, Pluri is a biotechnology pioneer focusing on scalable cell-based solutions that address global healthcare challenges.
Learn More
For more information about Pluri and its innovative technologies in the beauty industry, please visit their official website.
Frequently Asked Questions
What is the focus of the collaboration between Pluri and Miss Universe Skincare?
The collaboration focuses on developing innovative, exosome-based skincare products that enhance beauty and wellness.
What benefits do exosomes provide in skincare?
Exosomes are known to support skin rejuvenation, improving elasticity and radiance.
When is the first product expected to launch?
The first product is anticipated to be launched in the first half of 2026.
Who leads Cellav?
Cellav is led by Katty Dowery, a biotechnology executive with extensive experience in regenerative medicine.
How will products be distributed?
The products will be distributed through Miss Universe Skincare's global distribution channels.
